Unassociated Document
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
___________________
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) of the
SECURITIES
EXCHANGE ACT OF 1934
Date
of
Report (Date of earliest event reported): January 25, 2007
MEDICAL
DISCOVERIES, INC.
(Exact
name of registrant as specified in charter)
Utah
|
0-12627
|
87-0407858
|
(State
or other jurisdiction of incorporation)
|
(Commission
File Number)
|
(IRS
Employer Identification
No.)
|
|
|
|
|
|
|
1338
S. Foothill Drive, #266, Salt Lake City, Utah 84108
(Address
of principal executive offices)
|
Registrant’s
telephone number, including area code: (801)
582-9583
|
(Former
name or former address, if changed since last
report)
|
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
☐
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act
(17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act
(17 CFR 240.13e-4(c))
Item
5.02. Resignation
of Directors.
Verdis
Norton and Jody Olson resigned as directors of Medical Discoveries, Inc. (the
“Company”) effective as of January 25, 2007. The Company is also in receipt of
Larry Anderson’s resignation as a director of the Company, which is dated
effective as of December 1, 2006.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
|
|
MEDICAL
DISCOVERIES, INC.
|
|
|
|
Date: January
30, 2007 |
By: |
/s/ Judy
M.
Robinett |
|
Judy
M. Robinett |
|
President
and CEO
|